Cargando…

Impact of taxanes on androgen receptor signaling

The development and progression of metastatic castration-resistant prostate cancer is the major challenge in the treatment of advanced prostate cancer. The androgen receptor signaling pathway remains active in metastatic castration-resistant prostate cancer. Docetaxel and cabazitaxel are the first-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bai, Shanshan, Zhang, Bryan Y, Dong, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2019
Materias:	Invited Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6498725/ https://www.ncbi.nlm.nih.gov/pubmed/29900882 http://dx.doi.org/10.4103/aja.aja_37_18

Ejemplares similares

Human androgen deficiency: insights gained from androgen receptor knockout mouse models
por: Rana, Kesha, et al.
Publicado: (2014)

Transcriptional repression by androgen receptor: roles in castration-resistant prostate cancer
por: Gritsina, Galina, et al.
Publicado: (2019)

Selective androgen receptor modulators for the treatment of late onset male hypogonadism
por: Coss, Christopher C, et al.
Publicado: (2014)

Androgens and prostate disease
por: Cooper, Lori A, et al.
Publicado: (2014)

A sting in the tail: the N-terminal domain of the androgen receptor as a drug target
por: Monaghan, Amy E, et al.
Publicado: (2016)

Androgens and estrogens in skeletal sexual dimorphism
por: Laurent, Michaël, et al.
Publicado: (2014)

Androgen receptor variant-7: an important predictive biomarker in castrate resistant prostate cancer
por: Sartor, Oliver, et al.
Publicado: (2015)

PI3K-AKT-mTOR signaling in prostate cancer progression and androgen deprivation therapy resistance
por: Edlind, Merritt P, et al.
Publicado: (2014)

Registered report: androgen receptor splice variants determine taxane sensitivity in prostate cancer
por: Shan, Xiaochuan, et al.
Publicado: (2015)

Replication study: androgen receptor splice variants determine taxane sensitivity in prostate cancer
por: Shan, Xiaochuan, et al.
Publicado: (2018)

Approach to androgen excess in women: Clinical and biochemical insights
por: Cussen, Leanne, et al.
Publicado: (2022)

Androgen-deprivation therapy-induced aggressive prostate cancer with neuroendocrine differentiation
por: Lipianskaya, Julia, et al.
Publicado: (2014)

Androgen effects on skeletal muscle: implications for the development and management of frailty
por: O’Connell, Matthew DL, et al.
Publicado: (2014)

Androgen synthesis inhibitors in the treatment of castration-resistant prostate cancer
por: Stein, Mark N, et al.
Publicado: (2014)

Androgen receptor functions in prostate cancer development and progression
por: Balk, Steven P
Publicado: (2014)

Co-Targeting ErbB Receptors and the PI3K/AKT Axis in Androgen-Independent Taxane-Sensitive and Taxane-Resistant Human Prostate Cancer Cells
por: Adediran, Samusi, et al.
Publicado: (2022)

Recovery of spermatogenesis following testosterone replacement therapy or anabolic-androgenic steroid use
por: McBride, J Abram, et al.
Publicado: (2016)

The role of endogenous aryl hydrocarbon receptor signaling in cardiovascular physiology
por: Zhang, Nan
Publicado: (2011)

Improving intermittent androgen deprivation therapy: lessons learned from basic and translational research
por: Parikh, Rahul A, et al.
Publicado: (2014)

Collateral resistance to taxanes in enzalutamide‐resistant prostate cancer through aberrant androgen receptor and its variants
por: Shiota, Masaki, et al.
Publicado: (2018)

Long noncoding RNA-mediated activation of androgen receptor in prostate cancer
por: Petrovics, Gyorgy, et al.
Publicado: (2014)

Androgen receptor splice variants and polycystic ovary syndrome: cause or effect?
por: Walters, Kirsty A, et al.
Publicado: (2016)

Peroxisome proliferator-activated receptor gamma signaling in human sperm physiology
por: Liu, Li-Li, et al.
Publicado: (2015)

Raddeanin A down‐regulates androgen receptor and its splice variants in prostate cancer
por: Xia, Hongyan, et al.
Publicado: (2019)

Male androgen deficiency: a multisystem syndrome
por: Grossmann, Mathis, et al.
Publicado: (2014)

Mechanisms of signal transduction by ethylene: overlapping and non-overlapping signalling roles in a receptor family
por: Shakeel, Samina N., et al.
Publicado: (2013)

Androgen deprivation therapy in castrate-resistant prostate cancer: how important is GnRH agonist backbone therapy?
por: Merseburger, Axel S., et al.
Publicado: (2014)

Bone morphogenetic protein receptor signal transduction in human disease
por: Gomez‐Puerto, Maria Catalina, et al.
Publicado: (2018)

Interaction between c-jun and Androgen Receptor Determines the Outcome of Taxane Therapy in Castration Resistant Prostate Cancer
por: Tinzl, Martina, et al.
Publicado: (2013)

Association between SARS-CoV-2 infection and disease severity among prostate cancer patients on androgen deprivation therapy: a systematic review and meta-analysis
por: Sari Motlagh, Reza, et al.
Publicado: (2021)

Mechanisms of Taxane Resistance
por: Maloney, Sara M., et al.
Publicado: (2020)

Darolutamide: a novel androgen-signaling agent in nonmetastatic castration-resistant prostate cancer
por: Aragon-Ching, Jeanny B
Publicado: (2019)

Pathogenesis of RON receptor tyrosine kinase in cancer cells: activation mechanism, functional crosstalk, and signaling addiction
por: Wang, Ming-Hai, et al.
Publicado: (2013)

Correction: Interaction between c-jun and Androgen Receptor Determines the Outcome of Taxane Therapy in Castration Resistant Prostate Cancer
por: Tinzl, Martina, et al.
Publicado: (2018)

Androgen Receptor Signaling in Bladder Cancer
por: Li, Peng, et al.
Publicado: (2017)

Biased G Protein-Coupled Receptor Signaling: New Player in Modulating Physiology and Pathology
por: Bologna, Zuzana, et al.
Publicado: (2017)

Formylpeptide receptor 2: Nomenclature, structure, signalling and translational perspectives: IUPHAR review 35
por: Qin, Cheng Xue, et al.
Publicado: (2022)

Anti‐pruritic effect of isothiocyanates: Potential involvement of toll‐like receptor 3 signaling
por: Moriyama, Masaki, et al.
Publicado: (2022)

Impact of the mouse estrus cycle on cannabinoid receptor agonist‐induced molecular and behavioral outcomes
por: Kim, Hye Ji J., et al.
Publicado: (2022)

Gene-environment interactions in male reproductive health: Special reference to the aryl hydrocarbon receptor signaling pathway
por: Brokken, Leon J S, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_gbfcknsktr104a3qkk3e7kgcnn